GUANGZHOU, China--(BUSINESS WIRE)--Feb. 28, 2017--
Mannatech®,
Incorporated (NASDAQ: MTEX), a global health and wellness company
committed to transforming lives to make a better world, offers the
innovative nutritional supplement Ambrotose® which is
clinically proven to provide cognitive support for young adult functions
essential to reach their potential in the classroom. This is even more
critical now as success in the upcoming Zhongkao and Gao Kao are
essential for future academic advancement.
According to human clinical trials published in peer reviewed journals,
Ambrotose powders can positively impact brainwaves associated with
attention in young adults and improve memory and alertness in
middle-aged adults.
The cognitive factors of focus, attention and memory are crucial for
young adult students aiming for high academic achievement.
“Clinical studies conducted by independent scientists who are experts in
their fields have found that Ambrotose powder gives a helpful boost in
memory, focus and attention as well as providing perceived beneficial
changes in well-being,” said Dr. Rolando Maddela, MD, MPH, CCRP,
Mannatech’s Director of Clinical Research and Scientific Affairs. “For
young adults who are students, Ambrotose products can be a positive
addition to a comprehensive approach to academic achievement. Ambrotose
may also play an important role in the overall health and wellness of
students, a factor that also contributes to academic success.”
Dr. Maddela suggests that as little as four grams per day of Advanced
Ambrotose® powder or capsules may help support some of
the factors that contribute to success in the classroom.
Mannatech is the pioneer in developing Glyconutritional technology,
which includes Ambrotose powders. Ambrotose encourages cellular
communication and is shown to support cognitive functions – including
memory, focus and attention, as well as supporting the body’s immune and
digestive systems to encourage overall health.
Some of Mannatech’s Glyconutritional products are supported by
industry-standard clinical studies, including 17 human clinical trials
that have been published, 12 of which were double-blind,
placebo-controlled studies — the gold standard for product validation.
For more on Mannatech’s rigorous scientific research, please visit MannatechScience.org.
Advanced
Ambrotose is clinically tested to improve cognitive function and
support the body’s immune system.
For more information about Mannatech and its products, please visit www.MeiTaiChina.com.†^
About Mannatech
Mannatech, Incorporated, offers a profound wellness experience that
makes a difference in the lives of people across the world. Through its
innovative Glyconutrition products, Mannatech changes lives, providing
an unprecedented level of natural wellness, freedom and purpose. With
more than 20 years of experience and operations in 26 markets, Mannatech
is committed to transforming lives. For more information, visit MeiTaiChina.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain associates and
members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
†Customers who invite other customers to the Mannatech China
cross-border e-commerce site gain rewards for future product purchases
or cash redemption. The e-commerce business model is not multi-level
marketing or direct selling.
^Mannatech’s cross-border e-commerce model in China is a different
opportunity from Mannatech’s MLM business in other markets. Our
cross-border e-commerce model in China is not an MLM or direct selling
business.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170228006936/en/
Source: Mannatech, Incorporated
Mannatech, Incorporated
Raquel Mooring, 972-471-1532
pr@mannatech.com